Get started
VERTEX PHARMACEUTICALSVERTEX PHARMACEUTICALSVERTEX PHARMACEUTICALS

VERTEX PHARMACEUTICALS

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

1VRTX trade ideas

Vertex’s Stock Heads for All-Time HighVertex Pharmaceuticals Inc. shares were on track for an all-time high Wednesday after the company released new data from a trial of its investigational non-opioid pain medicine. The stock jumped more than 10% Wednesday morning, on pace for its largest percentage gain in more than three years, and was set to cross the $100 billion market-capitalization threshold for the first time. The company’s experimental pain medicine VX-548 produced statistically significant, clinically meaningfully reductions in pain intensity in people with diabetic peripheral neuropathy, a type of nerve damage that can affect people with diabetes, Vertex said in a release. The pain control seen with the drug appears comparable to the “gold standard” pain medicine pregabalin, which is marketed by Viatris Inc. under the brand name Lyrica, Evercore ISI analyst Liisa Bayko wrote in a report Wednesday. Evercore analysts raised their price target on Vertex shares to $405, from $389 previously. The new data on the pain medicine “looks at least as good as or better than investor expectations,” Jefferies analysts said in a note Wednesday. Vertex is working to quickly advance the treatment to Phase 3 studies in diabetic peripheral neuropathy, Vertex’s chief medical officer, Dr. Carmen Bozic, said in a statement. Phase 3 results from a trial of the drug in acute pain are expected in the first quarter of next year. Vertex shares have gained 37% in the year to date, while the S&P 500 is up 21%. NASDAQ:VRTX is trading above the 50, 100 & 200-day Moving Averages indicating the trend might continue.
NASDAQ:VRTXLong
by DEXWireNews
Vertex Pharmaceuticals: Riding the Bullish Wave with a Bull Put In the world of trading, there are a variety of strategies that investors can employ to maximize their returns. One such strategy that has gained popularity in recent years is the vertical spread bull put. This strategy involves buying a put option with a lower strike price and selling a put option with a higher strike price. Understanding Vertical Spread Bull Puts A vertical spread bull put is a type of options trading strategy that involves simultaneously buying and selling put options with different strike prices. The strategy is designed to benefit from a rise in the underlying stock price. Benefits of Vertical Spread Bull Puts Vertical spread bull puts offer several advantages to traders, including: Limited risk: The maximum loss on a vertical spread bull put is limited to the difference between the strike prices minus the premium paid for both options. Limited capital requirement: The trader only needs to invest the premium for both options, which is typically lower than the cost of purchasing a single option. Potential for high reward: If the underlying stock price rises significantly, the trader can profit significantly. Vertex Pharmaceuticals: A Potential Opportunity Vertex Pharmaceuticals (VRTX) is a biotechnology company that develops innovative medicines for the treatment of serious diseases. The company's stock price has been on an upward trend in recent months, and there is potential for further growth. Using Vertical Spread Bull Puts on VRTX A vertical spread bull put on VRTX could be a profitable trading strategy. For example, a trader could buy a put option with a strike price of $320 and sell a put option with a strike price of $310. The options would expire on January 19, 2024. Potential Profit If the VRTX stock price rises above $320 by January 19, 2024, the trader will keep the premium from both options, which will be a profit. Potential Loss If the VRTX stock price falls below $310 by January 19, 2024, the trader will lose the premium paid for both options. Conclusion Vertical spread bull puts can be a profitable trading strategy for investors who believe that an underlying stock price will rise in value. With careful analysis and risk management, traders can use this strategy to maximize their returns. DISCLAIMER Do your research: Before entering into any options trade, it is crucial to conduct thorough research on the underlying stock and the market conditions. Manage your risk: Set stop-loss orders to limit your potential losses. Use technical analysis: Technical analysis can help you identify potential entry and exit points for your trade. Practice before you trade: Demo accounts can provide a safe environment to practice your trading strategies
NASDAQ:VRTX
by pietropaolog
2
VRTX shortHi traders, let's have a look at VRTX analysis on daily timeframe. The support at 342$ has been retested many times however, this time we are expecting support to fail. If horizontal support fails and the price breaks upslopping support (blue line), it will look more bearish and short position can be taken. We define 3 targets which are shown on the chart. Reaching target 3 may take a lot of time, therefore patience is required. Enter short position only if the price breaks strong support. Do you agree?
NASDAQ:VRTXShort
by vf_investment
Trading Idea: Buy Vertex Pharmaceuticals (VRTX) StockVertex Pharmaceuticals (VRTX) has experienced a decline of around 5.84% in its share price over the past month. However, based on the provided facts, it appears that Vertex Pharmaceuticals is in a strong financial position and could be a good investment opportunity. Here is the core logic behind this trading idea: Net Income: Vertex Pharmaceuticals currently has a net income of $1 billion, indicating a strong profitability. Net Income Ratio: The net income ratio, calculated as revenues minus expenses, interest, and taxes, is currently at 41.69% for Vertex Pharmaceuticals. This high ratio suggests efficient cost management and profitability. Earnings Per Share (EPS): Vertex Pharmaceuticals generates $4 per share in earnings. This indicates a strong financial performance on a per-share basis. Diluted Earnings Per Share: The diluted earnings per share for Vertex Pharmaceuticals currently stands at $3.97. This shows that the company's earnings are not diluted significantly by additional shares. Total Current Assets: Vertex Pharmaceuticals possesses $13.87 billion in total current assets. This indicates a strong financial position and liquidity. Based on the provided facts, Vertex Pharmaceuticals meets the criteria for a low-risk mid-term investment strategy. The company has a high net income, a net income ratio of over 20%, earnings per share and diluted earnings per share of over 2, and total current assets in excess of 8 billion. Considering these factors, it could be a good idea to buy Vertex Pharmaceuticals (VRTX) stock for a short investment horizon and a moderate risk tolerance. Technical Outlook In the current state of affairs, Vertex Pharmaceuticals (VRTX) has climbed 28.17 away from its existing support level at 341.9. The stock price is now at $349.34. Vertex price action is receding away from a Fibonacci support level at $355.28. The stock has experienced a 3-day downtrend, shedding $20.61 or 5.57% in today's session. After hitting a low of 348.54 yesterday, Vertex settled at 349.34, consolidating its losses. Despite the recent downward movement, Vertex retains a "Neutral" rating. Here are some key facts about Vertex Pharmaceuticals: The stock has outperformed the Nasdaq by 6.12% so far this year. Vertex currently has a market cap of $90.16 billion. Yesterday, the trading volume for Vertex was 3.11 million, which is 227% higher than the average. In comparison to other themed assets, Eli Lilly and Company saw a decrease of 22.28 or 3.65% in yesterday's session, while Novo Nordisk lost 2.77 or 2.79%. On the other hand, Pfizer experienced a bullish session, soaring to 30.19 from 29.26.
NASDAQ:VRTXLong
by NomolosAI
1
VRTX: opened a new 10% positionWe have added a new position and here is a link to the updated portfolio: www.tradingview.com VRTX had a positive earnings surprise on Nov 6th which pushed the price up to new highs. These new highs have been followed by a natural pullback which occured under low trading volume. The new position has been added as the price broke through yesterdays high - a classical low risk pullback entry. VRTX shows an exceptional RS according to IBD criteria which makes this trade a high momentum play. General Selection Criteria: Introducing our cutting-edge trading strategy, a synergy of Cathy Wood's keen fundamental analysis and Mark Minervini's acclaimed trend template criteria. Imagine having the foresight to identify high-potential technology stocks that are not just promising on paper but are actively demonstrating robust performance in the market. That's the core of our approach. We meticulously select stocks that Cathy Wood's methodology identifies as leaders in technological innovation, ensuring that each company has a solid foundation for growth. But we don't stop there. We apply Mark Minervini's trend template to verify that these stocks are not only fundamentally sound but are also in a confirmed stage 2 uptrend. This dual-layered strategy ensures that you're investing in companies that are both revolutionizing their industries and are currently capturing the market's momentum. With our trading strategy, you're not just betting on potential; you're investing in technology stocks that are set to soar, backed by the analytical prowess of two of the most respected names in the trading world. Join us, and be part of a select group of traders who demand the best of both worlds: groundbreaking innovation and proven market trends.
NASDAQ:VRTXLong
by JS_TechTrading
Vertex at its VertexThe 1-2-3-4-5 Impulse Wave (blue wave) formation on VRTX is nearly complete. We can see a rising wedge (white colour) after impulse wave 3. This is impulse wave 5, which can be in the form of a wedge. VRTX is consolidating at the top. It may make one last effort to reach the top, form a double top and then break down. Another way to confirm formation of impulse wave 5 is to look for RSI divergence between wave 3 and wave 5. There, indeed is RSI divergence (yellow lines). We may soon expect start of A-B-C Corrective Wave.
NASDAQ:VRTXShort
by RS3175
Will Vertex Get More Vertical?Vertex Pharmaceuticals has been quietly sitting near record highs, and now some traders may look for movement to the upside. The first pattern on today’s chart is the tight consolidation pattern since early August. VRTX barely fell despite a steeper pullback in the broader market -- a potential sign of relative strength. The narrow range also pushed Bollinger Bandwidth to its narrowest since early 2020. Are prices due to start moving again? Next, the stock ended Monday at $352, its highest closing price in six weeks. That might draw fence sitters from the sidelines. Also consider the series of higher weekly lows since the spring. It could be a sign of buyers lurking near current prices. Finally, prices have remained near the 50- and 100-day simple moving averages (SMAs) without breaking under them. That could suggest the longer-term uptrend remains in effect. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NASDAQ:VRTX
by TradeStation
Symmetrical TrianglePrice appears to have been in a Rectangle which is a consolidation pattern. Rectangles are also known as Horizontal Trading Ranges and these can break up or down. This one broke to the upside. Looks like a rising wedge formed which is bearish in the end, although price can break upward from a rising wedge. Price fell out of the wedge to the downside. Rising wedges signal too much supply inside the wedge and both trendlines slope up and narrow at the apex. Small Symmetrical triangle has formed with the top line representing resistance and the bottom line is support. Triangles are neutral until broken with a trend in that direction. Some would wait for 2 closes in that direction, but this can vary. We are all different (o: Targets calculated using the width of the wide end of the triangle and Fib levels were applied. No recommendation.
NASDAQ:VRTX
by lauralea
3
VRTX Entry, Volume, Target, StopEntry: with price above 354.47 Volume: with volume greater than 2M Target: 391 area Stop: Depending on your risk tolerance; 342.3 gets you 3/1 Reward to Risk Ratio. This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not take this trade based on my idea, do not follow anyone blindly, do your own analysis and due diligence. I am not a professional trader.
NASDAQ:VRTXLong
by tradepatiently
Vertex Pulls Back to Old HighsVertex Pharmaceuticals broke out to new highs last month, and now it’s pulled back. The first pattern on today’s chart is the price area around $325, near the peaks in December and January. VRTX has dipped to revisit that level. Is old resistance becoming new support? Second, the drugmaker is attempting to hold the bottom of its Keltner Channel. Third, some chart matchers may view the recent slide as a completed A-B-C correction. That could make them think the pullback is nearing its end. Finally, stochastics have slid into oversold territory. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NASDAQ:VRTX
by TradeStation
1
VRTX seduces to to publish first idea I see a beautiful channel from the bottom of 2008. My concern is the bottom of october 2021 is the 4th time it touches (telling me being cautious because of possibly exhausting bullish trend) and the last weeks formed a rising wedge just under the middle of the 15 year channel. Also the top of july 2020 is too close, the "breakout" on 24th oct was not a really dominant candle, it can be false. If so, a double top can be confirmed in the next days when crossing $290 downwards. Still I'm a long position favouring guy, as a cup with handle (beginning from early august) seems to be confirmed, promising a $335 as target price. If that occurs in a couple of days, it can be considered as a valid breakout upwards from the wedge aiming ~$480 as target price. What do you think? :) NASDAQ:VRTX
NASDAQ:VRTX
by PaladinOfWealth
Up from a Rectangle/Deep Dive Down In to the RectangleDiving shadows on a candle may indicate trouble ahead. Diving Dojis and diving candle shadows can represent desperation. So far in my study on the divers, it is not good but have noted it is not an immediate negative response. This one went deep water diving looking for support and found it for the time being. Buyers came in and saved the day. For how long? That remains to be seen. I just have noted that when shadows and Dojis go diving, things can go bleak a bit later on, not usually immediately but I am still studying the divers. Perhaps if a stock is still at it's strongest, it does not have to dive to find support? Dunno and still working on this phenomena but so far it has been an ominous signal later on. There are rising wedges below price. Price broke up from 2 rectangles. Ascending triangle noted. VRTX does appear to be finding it's top but who knows. No recommendation. When a security starts deep water diving looking for buyers/support, it can spell trouble.
NASDAQ:VRTX
by lauralea